Randomized trial to assess safety/feasibility of memantine administration during residential treatment for alcohol use disorder: a pilot study

References

• Grant BF, Goldstein RB, Saha TD, Chou SP, Jung J, Zhang H, Pickering RP, Ruan WJ, Smith SM, Huang B, et al. Epidemiology of DSM-5 alcohol use disorder: results from the National Epidemiologic Survey on Alcohol and Related Conditions III. JAMA Psychiatry 2015;72:757–766. doi:10.1001/jamapsychiatry.2015.0584.
   PubMed Web of Science ®Google Scholar
• Moos RH, Moos BS. Rates and predictors of relapse after natural and treated remission from alcohol use disorders. Addiction 2006;101:212–222. doi:10.1111/j.1360-0443.2006.01310.x.
   PubMed Web of Science ®Google Scholar
• Bates ME, Bowden SC, Barry D. Neurocognitive impairment associated with alcohol use disorders: implications for treatment. Exp Clin Psychopharmacol 2002;10:193–212. doi:10.1037/1064-1297.10.3.193.
   PubMed Web of Science ®Google Scholar
• Heilig M, Egli M, Crabbe JC, Becker HC. Acute withdrawal, protracted abstinence and negative affect in alcoholism: are they linked? Addict Biol 2010;15:169–184. doi:10.1111/j.1369-1600.2009.00194.x.
   PubMed Web of Science ®Google Scholar
• Addolorato G, Leggio L, Abenavoli L, Gasbarrini G; Alcoholism Treatment Study Group. Neurobiochemical and clinical aspects of craving in alcohol addiction: a review. Addict Behav 2005;30:1209–1224. doi:10.1016/j.addbeh.2004.12.011.
   PubMed Web of Science ®Google Scholar
• Sinha R. Stress and addiction: a dynamic interplay of genes, environment, and drug intake. Biol Psychiatry 2009;66:100–101. doi:10.1016/j.biopsych.2009.05.003.
   PubMed Web of Science ®Google Scholar
• Pitel AL, Beaunieux H, Witkowski T, Vabret F, Guillery-Girard B, Quinette P, Desgranges B, Eustache F. Genuine episodic memory deficits and executive dysfunctions in alcoholic subjects early in abstinence. Alcoholism Clin Exp Res 2007;31:1169–1178. doi:10.1111/j.1530-0277.2007.00418.x.
   PubMed Web of Science ®Google Scholar
• Oscar-Berman M, Kirkley SM, Gansler DA, Couture A. Comparisons of Korsakoff and non-Korsakoff alcoholics on neuropsychological tests of prefrontal brain functioning. Alcohol Clin Exp Res 2004;28:667–675. doi:10.1097/01.ALC.0000122761.09179.B9.
   PubMed Web of Science ®Google Scholar
• Noel X, Bechara A, Dan B, Hanak C, Verbanck P. Response inhibition deficit is involved in poor decision making under risk in nonamnesic individuals with alcoholism. Neuropsychology 2007;21:778–786. doi:10.1037/0894-4105.21.6.778.
   PubMed Web of Science ®Google Scholar
• Zinn S, Stein R, Swartzwelder HS. Executive functioning early in abstinence from alcohol. Alcohol Clin Exp Res 2004;28:1338–1346. doi:10.1097/01.ALC.0000139814.81811.62.
   PubMed Web of Science ®Google Scholar
• Le Berre AP, Fama R, Sullivan EV. Executive Functions, Memory, and Social Cognitive Deficits and Recovery in Chronic Alcoholism: A Critical Review to Inform Future Research. Alcohol Clin Exp Res 2017;41:1432–1443. doi:10.1111/acer.13431.
   PubMed Web of Science ®Google Scholar
• Sullivan EV, Rosenbloom MJ, Pfefferbaum A. Pattern of motor and cognitive deficits in detoxified alcoholic men. Alcohol Clin Exp Res 2000;24:611–621.
   PubMed Web of Science ®Google Scholar
• Sullivan EV, Rosenbloom MJ, Lim KO, Pfefferbaum A. Longitudinal changes in cognition, gait, and balance in abstinent and relapsed alcoholic men: relationships to changes in brain structure. Neuropsychology 2000;14:178–188. doi:10.1037/0894-4105.14.2.178.
   PubMed Web of Science ®Google Scholar
• Smith DE, McCrady BS. Cognitive impairment among alcoholics: impact on drink refusal skill acquisition and treatment outcome. Addict Behav 1991;16:265–274. doi:10.1016/0306-(91)90019-E.
   PubMed Web of Science ®Google Scholar
• Kiluk BD, Nich C, Carroll KM. Relationship of cognitive function and the acquisition of coping skills in computer assisted treatment for substance use disorders. Drug Alcohol Depend 2011;114:169–176. doi:10.1016/j.drugalcdep.2010.09.019.
   PubMed Web of Science ®Google Scholar
• Becker JT, Jaffe JH. Impaired memory for treatment-relevant information in inpatient men alcoholics. J Stud Alcohol 1984;45:339–343. doi:10.15288/jsa.1984.45.339.
   PubMedGoogle Scholar
• Teichner G, Horner MD, Roitzsch JC, Herron J, Thevos A. Substance abuse treatment outcomes for cognitively impaired and intact outpatients. Addict Behav 2002;27:751–763. doi:10.1016/S-4603(01)00207-6.
   PubMed Web of Science ®Google Scholar
• Godding PR, Fitterling JM, Schmitz JM, Seville JL, Parisi SA. Discriminative utility of a brief cognitive status assessment with alcoholics and the impact of cognitive status on acquisition of treatment-relevant information. Psychol Addict Behav 1992;6:34–40. doi:10.1037/h0080602.
   Google Scholar
• Bates ME, Buckman JF, Nguyen TT. A role for cognitive rehabilitation in increasing the effectiveness of treatment for alcohol use disorders. Neuropsychol Rev 2013;23:27–47. doi:10.1007/s11065-013-9228-3.
   PubMed Web of Science ®Google Scholar
• Koob GF. Alcoholism: allostasis and beyond. Alcohol Clin Exp Res 2003;27:232–243. doi:10.1097/01.ALC.0000057122.36127.C2.
   PubMed Web of Science ®Google Scholar
• Sinha R. How does stress increase risk of drug abuse and relapse? Psychopharmacology (Berl) 2001;158:343–359. doi:10.1007/s002130100917.
   PubMed Web of Science ®Google Scholar
• Sinha R, Fuse T, Aubin L-R, O'Malley SS. Psychological stress, drug-related cues and cocaine craving. Psychopharmacology (Berl) 2000;152:140–148. doi:10.1007/s002130000499.
   PubMed Web of Science ®Google Scholar
• Barron S, Lewis B, Wellmann K, Carter M, Farook J, Ring J, Trent Rogers D, Holley R, Crooks P, Littleton J. Polyamine modulation of NMDARs as a mechanism to reduce effects of alcohol dependence. RPCN 2012;7:129–144. doi:10.2174/157488912800673128.
   Google Scholar
• Heinz A, Schafer M, Higley JD, Krystal JH, Goldman D. Neurobiological correlates of the disposition and maintenance of alcoholism. Pharmacopsychiatry 2003;36:S255–S258.
   PubMed Web of Science ®Google Scholar
• Krystal JH, Petrakis IL, Krupitsky E, Schütz C, Trevisan L, D'Souza DC. NMDA receptor antagonism and the ethanol intoxication signal: from alcoholism risk to pharmacotherapy. Ann N Y Acad Sci 2003;1003:176–184. doi:10.1196/annals.1300.010.
   PubMed Web of Science ®Google Scholar
• Pulvirenti L, Diana M. Drug dependence as a disorder of neural plasticity: focus on dopamine and glutamate. Rev Neurosci 2001;12:141–158. doi:10.1515/REVNEURO.2001.12.2.141.
   PubMed Web of Science ®Google Scholar
• Siggins GR, Martin G, Roberto M, Nie Z, Madamba S, Lecea L. Glutamatergic transmission in opiate and alcohol dependence. Ann N Y Acad Sci 2003;1003:196–211. doi:10.1196/annals.1300.012.
   PubMed Web of Science ®Google Scholar
• Backstrom P, Hyytia P. Ionotropic glutamate receptor antagonists modulate cue-induced reinstatement of ethanol-seeking behavior. Alcohol Clin Exp Res 2004;28:558–565.
   PubMed Web of Science ®Google Scholar
• Brown TE, Lee BR, Sorg BA. The NMDA antagonist MK-801 disrupts reconsolidation of a cocaine-associated memory for conditioned place preference but not for self-administration in rats. Learning Memory 2008;15:857–865. doi:10.1101/lm.1152808.
   PubMed Web of Science ®Google Scholar
• Gremel CM, Cunningham CL. Involvement of amygdala dopamine and nucleus accumbens NMDA receptors in ethanol-seeking behavior in mice. Neuropsychopharmacol 2009;34:1443–1453. doi:10.1038/npp.2008.179.
   PubMed Web of Science ®Google Scholar
• McGeehan AJ, Olive MF. The anti-relapse compound acamprosate inhibits the development of a conditioned place preference to ethanol and cocaine but not morphine. Br J Pharmacol 2003;138:9–12. doi:10.1038/sj.bjp.0705059.
   PubMed Web of Science ®Google Scholar
• Dunn RW, Corbett R, Fielding S. Effects of 5-HT1A receptor agonists and NMDA receptor antagonists in the social interaction test and the elevated plus maze. Eur J Pharmacol 1989;169:1–10. doi:10.1016/0014-(89)90811-X.
   PubMed Web of Science ®Google Scholar
• Mulholland PJ, Self RL, Harris BR, Little HJ, Littleton JM, Prendergast MA. Corticosterone increases damage and cytosolic calcium accumulation associated with ethanol withdrawal in rat hippocampal slice cultures. Alcohol Clin Exp Res 2005;29:871–881. doi:10.1097/01.ALC.0000163509.27577.DA.
   PubMed Web of Science ®Google Scholar
• Grant KA, Valverius P, Hudspith M, Tabakoff B. Ethanol withdrawal seizures and the NMDA receptor complex. Eur J Pharmacol 1990;176:289–296. doi:10.1016/0014-(90)90022-X.
   PubMed Web of Science ®Google Scholar
• Liljequist S. The competitive NMDA receptor antagonist, CGP 39551, inhibits ethanol withdrawal seizures. Eur J Pharmacol 1991;192:197–198. doi:10.1016/0014-(91)90092-5.
   PubMed Web of Science ®Google Scholar
• Rossetti ZL, Carboni S. Ethanol withdrawal is associated with increased extracellular glutamate in the rat striatum. Eur J Pharmacol 1995;283:177–183. doi:10.1016/0014-(95)00344-K.
   PubMed Web of Science ®Google Scholar
• Bleich S, Wiltfang J, Kornhuber J. Memantine in moderate-to-severe Alzheimer’s disease. N Engl J Med 2003;349:609–610. doi:10.1056/NEJM200308073490616.
   PubMed Web of Science ®Google Scholar
• Johnson JW, Kotermanski SE. Mechanism of action of memantine. Curr Opin Pharmacol 2006;6:61–67. doi:10.1016/j.coph.2005.09.007.
   PubMed Web of Science ®Google Scholar
• Kohr G. NMDA receptor antagonists: tools in neuroscience with promise for treating CNS pathologies. J Physiol 2007;581:1–2.
   PubMed Web of Science ®Google Scholar
• Lipton SA. Paradigm shift in neuroprotection by NMDA receptor blockade: memantine and beyond. Nat Rev Drug Discov 2006;5:160–170. doi:10.1038/nrd1958.
   PubMed Web of Science ®Google Scholar
• Rammes G, Danysz W, Parsons CG. Pharmacodynamics of memantine: an update. Curr Neuropharmacol 2008;6:55–78. doi:10.2174/157015908783769671.
   PubMed Web of Science ®Google Scholar
• Stepanyan TD, Farook JM, Kowalski A, Kaplan E, Barron S, Littleton JM. Alcohol withdrawal-induced hippocampal neurotoxicity in vitro and seizures in vivo are both reduced by memantine. Alcohol Clin Exp Res 2008;32:2128–2135. doi:10.1111/j.1530-0277.2008.00801.x.
   PubMed Web of Science ®Google Scholar
• Holter SM, Danysz W, Spanagel R. Evidence for alcohol anti-craving properties of memantine. Eur J Pharmacol 1996;314:R1–R2. (doi:10.1016/S-2999(96)00670-X.
   PubMed Web of Science ®Google Scholar
• Bienkowski P, Krzascik P, Koros E, Kostowski W, Scinska A, Danysz W. Effects of a novel uncompetitive NMDA receptor antagonist, MRZ 2/579 on ethanol self-administration and ethanol withdrawal seizures in the rat. Eur J Pharmacol 2001;413:81–89. doi:10.1016/S0014-2999(01)00743-9.
   PubMed Web of Science ®Google Scholar
• Lukoyanov NV, Paula-Barbosa MM. Memantine, but not dizocilpine, ameliorates cognitive deficits in adult rats withdrawn from chronic ingestion of alcohol. Neurosci Lett 2001;309:45–48. doi:10.1016/S-3940(01)02037-7.
   PubMed Web of Science ®Google Scholar
• Idrus NM, McGough NNH, Riley EP, Thomas JD. Administration of memantine during withdrawal mitigates overactivity and spatial learning impairments associated with neonatal alcohol exposure in rats. Alcohol Clin Exp Res 2014;38:529–537. doi:10.1111/acer.12259.
   PubMed Web of Science ®Google Scholar
• Cheon Y, Park J, Joe KH, Kim DJ. The effect of 12-week open-label memantine treatment on cognitive function improvement in patients with alcohol-related dementia. Int J Neuropsychopharm 2008;11:971–983. doi:10.1017/S1461145708008663.
   PubMed Web of Science ®Google Scholar
• Krupitsky EM, Neznanova O, Masalov D, Burakov AM, Didenko T, Romanova T, Tsoy M, Bespalov A, Slavina TY, Grinenko AA, et al. Effect of memantine on cue-induced alcohol craving in recovering alcohol-dependent patients. Am J Psychiatry 2007;164:519–523. doi:10.1176/ajp.2007.164.3.519.
   PubMed Web of Science ®Google Scholar
• Krupitsky EM, Rudenko AA, Burakov AM, Slavina TY, Grinenko AA, Pittman B, Gueorguieva R, Petrakis IL, Zvartau EE, Krystal JH. Antiglutamatergic strategies for ethanol detoxification: comparison with placebo and diazepam. Alcohol Clin Exp Res 2007;31:604–611. doi:10.1111/j.1530-0277.2007.00344.x.
   PubMed Web of Science ®Google Scholar
• Muhonen LH, Lahti J, Sinclair D, Lonnqvist J, Alho H. Treatment of alcohol dependence in patients with co-morbid major depressive disorder–predictors for the outcomes with memantine and escitalopram medication. Subst Abuse Treat Prev Policy 2008;3:20. doi:10.1186/1747-597X-3-20.
   PubMed Web of Science ®Google Scholar
• Muhonen LH, Lonnqvist J, Juva K, Alho H. Double-blind, randomized comparison of memantine and escitalopram for the treatment of major depressive disorder comorbid with alcohol dependence. J Clin Psychiatry 2008;69:392–399. doi:10.4088/JCP.v69n0308.
   PubMed Web of Science ®Google Scholar
• Arias AJ. Memantine for alcohol dependence: an open-label pilot study. Addict Disord Treat 2007;6:77–83. doi:10.1097/01.adt.0000210724.41187.4a.
   Google Scholar
• Parsons CG, Danysz W, Quack G. Memantine is a clinically well tolerated N-methyl-d-aspartate (NMDA) receptor antagonist-a review of preclinical data. Neuropharmacology 1999;38:735–767. doi:10.1016/s0028-3908(99)00019-2.
   PubMed Web of Science ®Google Scholar
• Bisaga A, Evans SM. Acute effects of memantine in combination with alcohol in moderate drinkers. Psychopharmacology (Berl) 2004;172:16–24. doi:10.1007/s00213-003-1617-5.[10.1007/s00213-003-5].
   PubMed Web of Science ®Google Scholar
• Evans SM, Levin FR, Brooks DJ, Garawi F. A pilot double-blind treatment trial of memantine for alcohol dependence. Alcoholism Clin Exp Res 2007;31:775–782. doi:10.1111/j.1530-0277.2007.00360.x.
   PubMed Web of Science ®Google Scholar
• Mann RE, Sobell LC, Sobell MB, Pavan D. Reliability of a family tree questionnaire for assessing family history of alcohol problems. Drug Alcohol Depend 1985;15:61–67. doi:10.1016/0376-(85)90030-4.
   PubMed Web of Science ®Google Scholar
• Miller WR, Tonigan JS, Longabaugh R; National Institute on Alcohol Abuse and Alcoholism (U.S.). The drinker inventory of consequences (DrInC): an instrument for assessing adverse consequences of alcohol abuse: test manual. Rockville, MD: U.S. Dept. of Health and Human Services, Public Health Service, National Institutes of Health, National Institute on Alcohol Abuse and Alcoholism; 1995.
   Google Scholar
• Feinn R, Tennen H, Kranzler HR. Psychometric properties of the short index of problems as a measure of recent alcohol-related problems. Alcohol Clin Exp Res 2003;27:1436–1441. doi:10.1097/01.ALC.0000087582.44674.AF.
   PubMed Web of Science ®Google Scholar
• Levine J, Schooler NR. SAFTEE: a technique for the systematic assessment of side effects in clinical trials. Psychopharmacol Bull 1986;22:343–381.
   PubMed Web of Science ®Google Scholar
• Sobell LC. Alcohol timeline followback (TLFB): handbook of psychiatric measures. Washington, DC: American Psychiatric Association; 2000. p. 477–479.
   Google Scholar
• Sobell LC, Sobell MB, Connors GJ, Agrawal S. Assessing drinking outcomes in alcohol treatment efficacy studies: selecting a yardstick of success. Alcohol Clin Exp Res 2003;27:1661–1666. doi:10.1097/01.ALC.0000091227.26627.75.
   PubMed Web of Science ®Google Scholar
• Tiffany ST. A critique of contemporary urge and craving research: methodological, psychometric, and theoretical issues. Adv Behav Res 1992;14:123–129. doi:10.1016/0146-(92)90005-9.
   Web of Science ®Google Scholar
• Tiffany ST, Drobes DJ. The development and initial validation of a questionnaire on smoking urges. Br J Addict 1991;86:1467–1476. doi:10.1111/j.1360-0443.1991.tb01732.x.
   PubMedGoogle Scholar
• Spielberger CD. Manual for State-Trait Anxiety Inventory. Palo Alto, CA: Consulting Psychologists Press; 1983.
   Google Scholar
• Beck AT, Steer RA, Brown GK. Beck depression inventory. 2nd ed. San Antonio, TX: The Psychological Corporation; 1996.
   Google Scholar
• Wechsler D. Wechsler Adult Intelligence Scale-Revised: manual. New York, NY: The Psychological Corporation; 1981.
   Google Scholar
• Reitan RM. The relation of the trail making test to organic brain damage. J Consult Psychol 1955;19:393–394. doi:10.1037/h0044509.
   PubMedGoogle Scholar
• Rennick PM, Russell M, Kempler H, Schwartz M. The effect of d-amphetamine on cognitive and perceptual- motor functions of hyperkinetic children. Paper presented at the Midwestern Psychological Association Meeting, Chicago, IL; 1972.
   Google Scholar
• Haghighi M, Jahangard L, Mohammad-Beigi H, Bajoghli H, Hafezian H, Rahimi A, Afshar H, Holsboer-Trachsler E, Brand S. In a double-blind, randomized and placebo-controlled trial, adjuvant memantine improved symptoms in inpatients suffering from refractory obsessive-compulsive disorders (OCD). Psychopharmacology (Berl) 2013;228:633–640. doi:10.1007/s00213-013-3067-z.
   PubMed Web of Science ®Google Scholar
• Hosenbocus S, Chahal R. Memantine: a review of possible uses in child and adolescent psychiatry. J Can Acad Child Adolesc Psychiatry 2013;22:166–171.
   PubMedGoogle Scholar
• Charles A, Flippen C, Romero Reyes M, Brennan KC. Memantine for prevention of migraine: a retrospective study of 60 cases. J Headache Pain 2007;8:248–250. doi:10.1007/s10194-007-0406-7[10.1007/s10194-007-7].
   PubMed Web of Science ®Google Scholar
• Bates ME, Buckman JF, Voelbel GT, Eddie D, Freeman J. The mean and the individual: integrating variable-centered and person-centered analyses of cognitive recovery in patients with substance use disorders. Front Psychiatry 2013;4:177. doi:10.3389/fpsyt.2013.00177.
   PubMedGoogle Scholar
• Stavro K, Pelletier J, Potvin S. Widespread and sustained cognitive deficits in alcoholism: a meta-analysis. Addict Biol 2013;18:203–213. doi:10.1111/j.1369-1600.2011.00418.x.
   PubMed Web of Science ®Google Scholar
• Bates ME, Voelbel GT, Buckman JF, Labouvie EW, Barry D. Short-term neuropsychological recovery in clients with substance use disorders. Alcohol Clin Exp Res 2005;29:367–377. doi:10.1097/01.ALC.0000156131.88125.2A.
   PubMed Web of Science ®Google Scholar
• Lewis B, Hoffman L, Garcia CC, Nixon SJ. Race and socioeconomic status in substance use progression and treatment entry. J Ethn Subst Abuse 2018;17:150–166.
   PubMed Web of Science ®Google Scholar
• Lewis B, Nixon SJ. Characterizing gender differences in treatment seekers. Alcohol Clin Exp Res 2014;38:275–284. doi:10.1111/acer.12228.
   PubMed Web of Science ®Google Scholar